David Barrett
Corporate Officer/Principal bei Flame Biosciences LLC
Profil
David J.
Barrett is currently the Head-Transition at Flame Biosciences LLC.
He previously worked as a Director at Fortress Biotech, Inc. and held CFO positions at Overture Financial Services LLC, Ventrus Biosciences, Inc., Overture Asset Managers LLC, and Woodbrook Group Holdings, Inc. He was also the CFO, COO & Principal Accounting Officer at Assembly Biosciences, Inc. from 2015 to 2018.
Barrett received his undergraduate and graduate degrees from the University of Florida in 1999.
Aktive Positionen von David Barrett
Unternehmen | Position | Beginn |
---|---|---|
Flame Biosciences LLC
Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Corporate Officer/Principal | 01.04.2019 |
Ehemalige bekannte Positionen von David Barrett
Unternehmen | Position | Ende |
---|---|---|
ASSEMBLY BIOSCIENCES, INC. | Finanzdirektor/CFO | 08.03.2018 |
WOODBROOK GROUP HOLDINGS INC. | Finanzdirektor/CFO | 21.07.2009 |
Overture Financial Services LLC
Overture Financial Services LLC Investment ManagersFinance Overture Financial Services LLC specializes in institutional consulting services, infrastructure design, systems implementation and project management for sovereign wealth funds, central banks, social security systems, and financial institutions. The company is headquartered in New York, NY. | Finanzdirektor/CFO | 01.04.2006 |
Overture Asset Managers LLC
Overture Asset Managers LLC Investment ManagersFinance Overture Asset Managers LLC acquires boutique money managers and provides investment management services. The private company is based in New York, NY. | Finanzdirektor/CFO | 01.01.2005 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.09.2003 |
Ausbildung von David Barrett
University of Florida | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
WOODBROOK GROUP HOLDINGS INC. | Finance |
FORTRESS BIOTECH, INC. | Health Technology |
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Overture Financial Services LLC
Overture Financial Services LLC Investment ManagersFinance Overture Financial Services LLC specializes in institutional consulting services, infrastructure design, systems implementation and project management for sovereign wealth funds, central banks, social security systems, and financial institutions. The company is headquartered in New York, NY. | Finance |
Overture Asset Managers LLC
Overture Asset Managers LLC Investment ManagersFinance Overture Asset Managers LLC acquires boutique money managers and provides investment management services. The private company is based in New York, NY. | Finance |
Ventrus Biosciences, Inc.
Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ventrus Biosciences, Inc. is a development stage specialty pharmaceutical company engages in development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoidal disease, anal fissures, and fecal incontinence. Its major pharmaceutical progress made in the gastrointestinal therapeutic areas of gastroesophageal reflux, peptic ulcer disease, and inflammatory bowel disease. Ventrus Biosciences products includes VEN 307 (topical diltiazem), is intended to treat pain associated with anal fissures and VEN 308 (topical phenylephrine), is intended to treat fecal incontinence. The company was founded on October 10, 2005 and is headquartered in New York, NY. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Flame Biosciences LLC
Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Commercial Services |